DK1644049T3 - Fremgangsmåde og anordning til radioterapi - Google Patents

Fremgangsmåde og anordning til radioterapi

Info

Publication number
DK1644049T3
DK1644049T3 DK04730355T DK04730355T DK1644049T3 DK 1644049 T3 DK1644049 T3 DK 1644049T3 DK 04730355 T DK04730355 T DK 04730355T DK 04730355 T DK04730355 T DK 04730355T DK 1644049 T3 DK1644049 T3 DK 1644049T3
Authority
DK
Denmark
Prior art keywords
predetermined
radon
radium
tumor
time period
Prior art date
Application number
DK04730355T
Other languages
Danish (da)
English (en)
Inventor
Itzhak Kelson
Lior Arazi
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Application granted granted Critical
Publication of DK1644049T3 publication Critical patent/DK1644049T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1014—Intracavitary radiation therapy
    • A61N5/1015—Treatment of resected cavities created by surgery, e.g. lumpectomy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00064—Constructional details of the endoscope body
    • A61B1/00071—Insertion part of the endoscope body
    • A61B1/0008—Insertion part of the endoscope body characterised by distal tip features
    • A61B1/00087—Tools
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/012—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor
    • A61B1/018—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor characterised by internal passages or accessories therefor for receiving instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/313—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for introducing through surgical openings, e.g. laparoscopes
    • A61B1/3132—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for introducing through surgical openings, e.g. laparoscopes for laparoscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1007—Arrangements or means for the introduction of sources into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1027—Interstitial radiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/06—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the coating material
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
    • C23C14/48—Ion implantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1007—Arrangements or means for the introduction of sources into the body
    • A61N2005/1008—Apparatus for temporary insertion of sources, e.g. afterloaders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019—Sources therefor
    • A61N2005/1024—Seeds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/1087—Ions; Protons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK04730355T 2003-04-30 2004-04-29 Fremgangsmåde og anordning til radioterapi DK1644049T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46640803P 2003-04-30 2003-04-30
PCT/IL2004/000363 WO2004096293A2 (fr) 2003-04-30 2004-04-29 Procede et dispositif pour radiotherapie

Publications (1)

Publication Number Publication Date
DK1644049T3 true DK1644049T3 (da) 2008-02-04

Family

ID=33418374

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04730355T DK1644049T3 (da) 2003-04-30 2004-04-29 Fremgangsmåde og anordning til radioterapi

Country Status (12)

Country Link
US (6) US8894969B2 (fr)
EP (2) EP1644049B1 (fr)
JP (2) JP4998916B2 (fr)
KR (2) KR101130187B1 (fr)
AT (2) ATE424221T1 (fr)
AU (1) AU2010201870B2 (fr)
CA (1) CA2523646C (fr)
DE (2) DE602004009184T2 (fr)
DK (1) DK1644049T3 (fr)
ES (1) ES2294496T3 (fr)
HK (1) HK1107283A1 (fr)
WO (1) WO2004096293A2 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1644049T3 (da) * 2003-04-30 2008-02-04 Univ Ramot Fremgangsmåde og anordning til radioterapi
WO2006137051A1 (fr) 2005-06-20 2006-12-28 Ramot At Tel Aviv University Ltd. Dispositif et méthode pour positionner une substance dans un tissu
PL1909855T3 (pl) * 2005-07-26 2018-09-28 Aplha Tau Medical Ltd. Promieniotwórcze źródło powierzchniowe i sposób jego wytwarzania
JP5123183B2 (ja) * 2005-08-25 2013-01-16 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 標的療法のための画像ベースの計画方法及び装置
WO2007064900A2 (fr) * 2005-12-02 2007-06-07 Xoft, Inc. Traitement de lesions ou d'imperfections de tissus mammaliens cutanes ou proches de la peau ou dans ou pres d'autres surfaces anatomiques
US20100015042A1 (en) * 2008-07-03 2010-01-21 Ramot At Tel Aviv University Ltd. Combine radiation therapy and chemotherapy for treating cancer
US20100142678A1 (en) * 2008-12-08 2010-06-10 Electronics And Telecommunications Research Institute Minimally invasive particle beam cancer therapy apparatus
US9821174B1 (en) 2015-02-06 2017-11-21 Gammatile Llc Radioactive implant planning system and placement guide system
US10888710B1 (en) 2016-11-29 2021-01-12 Gt Medical Technologies, Inc. Transparent loading apparatus
RU2763750C2 (ru) * 2017-05-11 2022-01-10 Альфа Тау Медикал Лтд. Полимерные покрытия для брахитерапевтических устройств
SG11202007645TA (en) 2018-03-08 2020-09-29 Alpha Tau Medical Ltd Radiotherapy seeds and applicators
WO2019193464A1 (fr) * 2018-04-02 2019-10-10 Alpha Tau Medical Ltd. Libération contrôlée de radionucléides
CA3114299A1 (fr) 2018-11-01 2020-05-07 Alpha Tau Medical Ltd. Rayonnement alpha-emetteur intratumoral et activation de capteurs cytoplasmiques pour un agent pathogene intracellulaire
CA3152075A1 (fr) 2019-10-10 2021-04-15 Alpha Tau Medical Ltd. Preparation humide de sources de radiotherapie
CN112462406B (zh) * 2020-11-11 2024-03-19 核工业北京地质研究院 一种深部铀矿化放射性及深穿透地球化学组合识别方法
US11872409B2 (en) 2020-11-12 2024-01-16 Alpha Tau Medical Ltd. Radiotherapy template assembly
US11857803B2 (en) 2020-12-16 2024-01-02 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy with enhanced beta treatment
US11666781B2 (en) 2021-01-05 2023-06-06 Alpha Tau Medical Ltd. Treatment planning for alpha particle radiotherapy
US11666782B2 (en) 2021-01-05 2023-06-06 Alpha Tau Medical Ltd. Treatment planning for alpha particle radiotherapy
JP2024509768A (ja) * 2021-03-11 2024-03-05 アルファ タウ メディカル リミテッド 放射線治療アプリケータ
US20220395706A1 (en) * 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for breast and prostate cancer
US20220395700A1 (en) * 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for colon cancer
US11964168B2 (en) 2021-06-10 2024-04-23 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for prostate cancer
US20220395702A1 (en) * 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for glioblastoma
US20220395703A1 (en) * 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Activity levels for diffusing alpha-emitter radiation therapy
US12042668B2 (en) 2021-06-10 2024-07-23 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for squamous cell carcinoma
US12070620B2 (en) 2021-06-10 2024-08-27 Alpha Tau Medical Ltd. Activity levels for diffusing alpha-emitter radiation therapy
US12076582B2 (en) 2021-06-10 2024-09-03 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for colorectal cancer
US12076583B2 (en) 2021-06-10 2024-09-03 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for melanoma
US12064643B2 (en) 2021-06-10 2024-08-20 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for breast cancer
US12070621B2 (en) 2021-06-10 2024-08-27 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for pancreatic cancer
US20220401755A1 (en) * 2021-06-10 2022-12-22 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for squamous cell carcinoma
US20220395704A1 (en) * 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for melanoma
US20220395701A1 (en) * 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for pancreatic cancer
US12076581B2 (en) 2021-06-10 2024-09-03 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for glioblastoma
CA3222415A1 (fr) 2021-06-30 2023-01-05 Alpha Tau Medical Ltd. Applicateur de radiotherapie a distribution radiale perpendiculaire ou inclinee
US12053644B2 (en) 2021-12-30 2024-08-06 Gt Medical Technologies, Inc. Radiation shielding apparatus for implantable radioactive seeds

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1810528A1 (de) * 1968-11-23 1970-06-04 Messerschmitt Boelkow Blohm Radionuklidgenerator
US4107283A (en) 1976-07-19 1978-08-15 New England Nuclear Corporation Tracer for circulation determinations
DE3241589A1 (de) * 1982-11-10 1984-05-17 Pfaudler-Werke Ag, 6830 Schwetzingen Implantate und verfahren zu deren herstellung
FR2541720B1 (fr) 1983-02-24 1987-05-22 Citroen Sa Arbre a cames frittees collees
US4976680A (en) * 1988-10-07 1990-12-11 Hayman Michael H Apparatus for in situ radiotherapy
US5342283A (en) * 1990-08-13 1994-08-30 Good Roger R Endocurietherapy
US6099457A (en) * 1990-08-13 2000-08-08 Endotech, Inc. Endocurietherapy
JP3406661B2 (ja) * 1993-12-06 2003-05-12 日本メジフィジックス株式会社 注射筒シース
US5713828A (en) * 1995-11-27 1998-02-03 International Brachytherapy S.A Hollow-tube brachytherapy device
JP2000509014A (ja) 1996-03-11 2000-07-18 フォーカル，インコーポレイテッド 放射性核種および放射性医薬品のポリマー送達
DE19724230C1 (de) * 1997-04-30 1998-11-26 Schering Ag Radioaktiv beschichtete Stents, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
JP2001509493A (ja) * 1997-07-11 2001-07-24 インナーダイン， インコーポレイテッド 放射送達構造体の調製およびシール化のための方法およびシステム
US6419621B1 (en) * 1997-10-24 2002-07-16 Radiomed Corporation Coiled brachytherapy device
US6030333A (en) * 1997-10-24 2000-02-29 Radiomed Corporation Implantable radiotherapy device
US6394945B1 (en) 1997-12-22 2002-05-28 Mds (Canada), Inc. Radioactively coated devices
US6077413A (en) * 1998-02-06 2000-06-20 The Cleveland Clinic Foundation Method of making a radioactive stent
US6060036A (en) * 1998-02-09 2000-05-09 Implant Sciences Corporation Radioactive seed implants
US20020131935A1 (en) * 1998-04-10 2002-09-19 Fisher Darrell R. Fibrin carrier compound for treatment of disease
WO2000006243A2 (fr) 1998-07-28 2000-02-10 Innerdyne, Inc. Dispositifs absorbables d'apport pour curietherapie et chimiotherapie et procedes correspondants
US6676595B1 (en) * 1998-08-24 2004-01-13 Varian Medical Systems Technologies, Inc. Radioactive medical implant and method of manufacturing
JP2002530128A (ja) * 1998-11-18 2002-09-17 ラジオバスキュラー、システムズ、リミテッド、ライアビリティ、カンパニー 放射性コーティング溶液、方法および基板
US20020077520A1 (en) * 1998-11-18 2002-06-20 Jerome Segal Device and method for dilating and irradiating a vascular segment or body passageway
NO310544B1 (no) * 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
US6224536B1 (en) * 1999-02-08 2001-05-01 Advanced Cardiovascular Systems Method for delivering radiation therapy to an intravascular site in a body
US6391911B1 (en) 1999-02-26 2002-05-21 Robert E. Bases Coadministration of lucanthone and radiation for treatment of cancer
US6059714A (en) * 1999-03-26 2000-05-09 Implant Sciences Corporation Radioactive medical devices
US6392068B1 (en) 1999-07-07 2002-05-21 The University Of Georgia Research Foundation, Inc. Carborane containing cholesterol, a new type of molecule for targeted boron drug delivery
EP1235598A2 (fr) 1999-11-12 2002-09-04 Angiotech Pharmaceuticals, Inc. Compositions et methodes destinees au traitement de maladies utilisant une therapie radioactive et des inhibiteurs du cycle cellulaire combines
US6575888B2 (en) 2000-01-25 2003-06-10 Biosurface Engineering Technologies, Inc. Bioabsorbable brachytherapy device
CA2320557A1 (fr) 2000-09-25 2002-03-25 Michelangelo Delfino Implant medical radioactif et methode pour sa fabrication
EP1232770A1 (fr) 2001-02-15 2002-08-21 AEA Technology QSA GmbH Capsule radioactive
US6723052B2 (en) * 2001-06-07 2004-04-20 Stanley L. Mills Echogenic medical device
CN100566711C (zh) 2002-04-15 2009-12-09 斯隆-凯特林癌症研究院 治疗癌症的化合物及其用途
WO2004064727A2 (fr) 2003-01-16 2004-08-05 Georgetown University Procedes pour utiliser des inhibiteurs de l'histone deacetylase en tant qu'agents synergiques dans la therapie du cancer
US20060039858A1 (en) * 2003-02-11 2006-02-23 Ekaterina Dadachova Radiolabeled antibodies and peptides for treatment of tumors
DK1644049T3 (da) 2003-04-30 2008-02-04 Univ Ramot Fremgangsmåde og anordning til radioterapi
GB0423565D0 (en) 2004-10-22 2004-11-24 Algeta As Formulation
PL1909855T3 (pl) 2005-07-26 2018-09-28 Aplha Tau Medical Ltd. Promieniotwórcze źródło powierzchniowe i sposób jego wytwarzania

Also Published As

Publication number Publication date
ES2294496T3 (es) 2008-04-01
US20180345038A1 (en) 2018-12-06
CA2523646A1 (fr) 2004-11-11
DE602004019826D1 (de) 2009-04-16
KR101130187B1 (ko) 2012-03-29
KR101167262B1 (ko) 2012-07-23
JP2007536940A (ja) 2007-12-20
AU2010201870B2 (en) 2012-04-26
JP5226721B2 (ja) 2013-07-03
JP4998916B2 (ja) 2012-08-15
US20090311413A1 (en) 2009-12-17
US8834837B2 (en) 2014-09-16
AU2010201870A1 (en) 2010-06-03
WO2004096293A3 (fr) 2004-12-29
US20070041900A1 (en) 2007-02-22
KR20060015567A (ko) 2006-02-17
DE602004009184D1 (de) 2007-11-08
DE602004009184T2 (de) 2008-07-03
US10058713B2 (en) 2018-08-28
US20090311173A1 (en) 2009-12-17
EP1644049B1 (fr) 2007-09-26
ATE424221T1 (de) 2009-03-15
WO2004096293A2 (fr) 2004-11-11
AU2004233763A1 (en) 2004-11-11
US20150104560A1 (en) 2015-04-16
ATE374045T1 (de) 2007-10-15
EP1644049A2 (fr) 2006-04-12
US8894969B2 (en) 2014-11-25
EP2060274B1 (fr) 2014-03-26
KR20110094124A (ko) 2011-08-19
JP2010162373A (ja) 2010-07-29
HK1107283A1 (en) 2008-04-03
EP2060274A1 (fr) 2009-05-20
CA2523646C (fr) 2012-07-03
US20100062143A1 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
DK1644049T3 (da) Fremgangsmåde og anordning til radioterapi
IL175387A0 (en) Implantable radiotherapy/brachytherapy radiation detecting apparatus and methods
AU2003299549A8 (en) Apparatus and method for dose administration in brachytherapy
DE60324427D1 (de) Verfahren zur modulation der tubulindeacetylase-aktivität
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
DK1539166T3 (da) Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
TW200518752A (en) Combinations of drugs for the treatment of neoplasms
DE602004025726D1 (de) Pharmazeutische verbindung zur behandlung von lokal fortgeschrittenem primär inoperablen pankreaskarzinom (lapc).
WO2005061009A3 (fr) Microparticules pour imagerie et radiotherapie de micro-arteres
ATE403190T1 (de) Computergestüztes und ferngesteuertes infusionstherapiesystem
DE60131775D1 (de) Eine implantierbare oder einführbare vorrichtung zur abgabe therapeutischer mittel
WO2005084296A3 (fr) Composes tricycliques fusionnes en tant qu'inhibiteurs de 17beta-hydroxysteroide deshydrogenase 3
ATE517632T1 (de) Niedrigdosierte verfahren zur behandlung von erkrankungen, bei denen tnf-alpha-aktivität schädlich ist
IL179515A0 (en) Method of administering and using vegf inhibitors for the treatment of human cancer
CY1110162T1 (el) Φαρμακοτεχνικη μορφη και μεθοδοι για την αγωγη της θρομβοκυτταραιμιας
TW200630089A (en) Treatment methods
ATE438391T1 (de) Pharmazeutische zubereitungen von amyloid- hemmenden verbindungen
TW200724158A (en) Combination therapy in the treatment of cancer
DE60331827D1 (de) Zusammensetzungen für die radioimmuntherapie von gehirn-tumoren
DK1411961T3 (da) Anvendelse af ekstrakter af Ginkgo biloba til at fremstille et lægemiddel, der er beregnet til at behandle sarkopeni
MXPA05010804A (es) Torio 227 para uso en radioterapia de enfermedades del tejido blando.
SG112006A1 (en) Radioactive arsenic-containing compounds and their uses in the treatment of tumors
EP1817062A4 (fr) Dosimetrie des rayonnements et anticorps bloquants et leurs methodes d'utilisation dans le traitement du cancer
AU2003269378A8 (en) Methods and compositions for diagnosing and treating companion animal cancer
TW200501958A (en) A therapeutic agent for treating a behavioral disorder